![Yusuke Nakamura](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Vermogen: 6 M $ op 31-07-2026
Yusuke Nakamura is currently the President of the National Institutes of Biomedical Innovation, Health & Nutrition.
He previously worked as a Director at OncoTherapy Science, Inc.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
20,53% | 31-10-2025 | 1.000.000 ( 20,53% ) | 4 M $ | 31-07-2026 |
| 30-09-2025 | 12.511.000 ( 3,06% ) | 1 M $ | 31-07-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
Natl Institutes of Biomedical Innovation, Health & Nutrition
 Natl Institutes of Biomedical Innovation, Health & Nutrition General GovernmentGovernment Operates as a research organization that will contribute to the development of pharmaceuticals in Japan | President | - |
| Bedrijven | Functie | Einde |
|---|---|---|
| ONCOTHERAPY SCIENCE, INC. | Directeur/Bestuurslid | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
| Bedrijven in privébezit | 2 |
|---|---|
OncoTherapy Science, Inc.
 OncoTherapy Science, Inc. BiotechnologyHealth Technology Engages in the research and development of cancer vaccines and antibody drugs | Health Technology |
Natl Institutes of Biomedical Innovation, Health & Nutrition
Natl Institutes of Biomedical Innovation, Health & Nutrition General GovernmentGovernment Operates as a research organization that will contribute to the development of pharmaceuticals in Japan | Government |
Kies jouw editie
Alle financiële informatie op nationaal niveau
